Stockscreener 앱 받기
9.12
1.11%
0.10
시간 외 거래:
9.13
0.01
+0.11%
Immunome Inc 주식(IMNM)의 최신 뉴스
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 563 - GuruFocus
Immunome Reports Inducement Grants Under Nasdaq Listing Rule - marketscreener.com
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Two Sigma Advisers LP Makes New $512,000 Investment in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome, Inc. (NASDAQ:IMNM) Shares Sold by Nuveen Asset Management LLC - Defense World
Insider Buying: Jean Bienaime Acquires Additional Shares of Immunome Inc (IMNM) - GuruFocus
Two Sigma Investments LP Purchases Shares of 154,467 Immunome, Inc. (NASDAQ:IMNM) - Defense World
14,477 Shares in Immunome, Inc. (NASDAQ:IMNM) Acquired by ProShare Advisors LLC - Defense World
Millennium Management LLC Buys New Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
BNP Paribas Financial Markets Invests $70,000 in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Deutsche Bank AG Has $489,000 Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Wall Street Analysts Think Immunome (IMNM) Could Surge 188.57%: Read This Before Placing a Bet - MSN
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
(IMNM) Trading Report - news.stocktradersdaily.com
Immunome to Present at Upcoming Investor Conferences - BioSpace
Cancer Therapy Developer Immunome Set for TD Cowen and Goldman Sachs Healthcare Conferences - Stock Titan
Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Northern Trust Corp - Defense World
Immunome, Inc. Reports Q1 2025 Financial Results - TipRanks
Immunome stock rating cut to Hold by Boral Capital - Investing.com Nigeria
Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates - MSN
Leerink Partnrs Has Strong Estimate for Immunome Q2 Earnings - Defense World
Voya Investment Management LLC Has $166,000 Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
All You Need to Know About Immunome (IMNM) Rating Upgrade to Buy - MSN
Immunome (NASDAQ:IMNM) Shares Gap Up Following Earnings Beat - Defense World
Immunome (IMNM) Financial Update and Clinical Progress in Q1 202 - GuruFocus
Wedbush Adjusts Price Target on Immunome to $21 From $33, Maintains Outperform Rating - marketscreener.com
(IMNM) Investment Report - news.stocktradersdaily.com
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace
Immunome Inc (IMNM) Q1 2025 Earnings: EPS Loss of $0.52 Beats Es - GuruFocus
Immunome Q1 Income From Operations USD -44.636 Million - marketscreener.com
Immunome Expands Share Reserve in Inducement Plan - TipRanks
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update | IMNM Stock News - GuruFocus
Raymond James Financial Inc. Makes New $274,000 Investment in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome (IMNM) Financial Update and Clinical Progress in Q1 2025 | IMNM Stock News - GuruFocus
Wall Street Analysts Believe Immunome (IMNM) Could Rally 249.93%: Here's is How to Trade - MSN
Immunome (IMNM) Expected to Announce Earnings on Tuesday - Defense World
MetLife Investment Management LLC Purchases 5,354 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome, Inc. (NASDAQ:IMNM) Shares Purchased by Wells Fargo & Company MN - Defense World
Invesco Ltd. Cuts Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Brokerages Set Immunome, Inc. (NASDAQ:IMNM) Price Target at $25.33 - Defense World
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IMNM Stock News - GuruFocus
0.86%
1.24%
자본화:
|
볼륨(24시간):